Dr Oliver Lily


Dr Oliver Lily graduated with honours in medicine from Leeds University and completed a first-class degree in pharmacology, including studying the effects of medications on the brain. He trained as a junior doctor at St James Hospital and Leeds General Infirmary before researching the causes of MS at the Institute of Molecular Medicine at Oxford University.

Oliver is Currently Lead Clinician in the Neurology Department at Leeds, seeing patients in Leeds and Harrogate. Over the years he has been an investigator in many pivotal trials of MS therapy such as Interferons, Tysabri and Teriflunamide.

Oliver’s research interests continue to be Clinical Trials in MS as well as Neuro-immunology and Neuro-opthalmology.